Science Explorer Back to mapMap
Discussion
Researcher · Cellerant Therapeutics (United States) · United States

T. Fong

T. Fong publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Immune Cell Function and Interaction, Immunotherapy and Immune Responses and Immune Response and Inflammation.

OpenAlex
World rank
#5,635,803
of 7,710,434 ranked researchers
Rank in United States
#1,407,850
of 1,627,098
Works
20
Citations
265
Citations per work
13.3
h-index
7
i10-index 7Top 90% in Immunology
T. Fong

What does T. Fong research?

T. Fong's work is mostly in Immunology and Microbiology (28%), Medicine (26%), Biochemistry, Genetics and Molecular Biology (7%).

Life Sciences: 7 works · 35.2% of their workImmunology and Microbiology: 6 works · 27.8% of their workImmunology: 6 works · 27.8% of their workBiochemistry, Genetics and Molecular Biology: 1 works · 7.4% of their workMolecular Biology: 1 works · 7.4% of their workEverything else: 7 works · 33.2% of their workHealth Sciences: 5 works · 26.0% of their workMedicine: 5 works · 26.0% of their workOncology: 3 works · 14.8% of their workGenetics: 1 works · 5.6% of their workHematology: 1 works · 5.6% of their workPhysical Sciences: 1 works · 5.6% of their workEngineering: 1 works · 5.6% of their workAerospace Engineering: 1 works · 5.6% of their workTHEIR WORKT. Fong20works
Life Sciences35%Physical Sciences6%Health Sciences26%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology627.8%
    2. Biochemistry, Genetics and Molecular Biology17.4%
  2. Everything else733.2%
    1. Medicine526.0%
    1. Engineering15.6%
  1. 1Immunology28% of their works
  2. 2Oncology15% of their works
  3. 3Molecular Biology7% of their works
  4. 4Aerospace Engineering6% of their works
  5. 5Hematology6% of their works
  6. 6Genetics6% of their works

Research topics

Which keywords describe T. Fong's research?

The keywords of their largest research topics: Cancer Immunotherapy, Dendritic Cells, Immunity, Natural Killer Cells, NK Cell Recognition, Pattern Recognition Receptors, Toll-like Receptors and Antimicrobial Agents.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 17 words, with their numbers
  1. Cancer Immunotherapy72 topics
  2. Dendritic Cells41 topic
  3. Immunity41 topic
  4. NK Cell Recognition41 topic
  5. Natural Killer Cells41 topic
  6. Pattern Recognition Receptors41 topic
  7. Toll-like Receptors41 topic
  8. Antimicrobial Agents31 topic
  9. Bone Marrow Niche31 topic
  10. CAR T Cells31 topic
  11. Chimeric Antigen Receptor31 topic
  12. Febrile Neutropenia31 topic
  13. Hematopoietic Stem Cells31 topic
  14. Foxp321 topic
  15. Gene Therapy21 topic
  16. TGF-ß21 topic
  17. Viral Vectors21 topic

Where does T. Fong work?

T. Fong's main affiliation in the publication record is Cellerant Therapeutics (United States), United States.

How many publications and citations does T. Fong have?

OpenAlex counts 20 works and 265 citations for T. Fong, an h-index of 7, ranking #5,635,803 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about T. Fong. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.